IL152892A0 - Cannabinoid drugs - Google Patents

Cannabinoid drugs

Info

Publication number
IL152892A0
IL152892A0 IL15289201A IL15289201A IL152892A0 IL 152892 A0 IL152892 A0 IL 152892A0 IL 15289201 A IL15289201 A IL 15289201A IL 15289201 A IL15289201 A IL 15289201A IL 152892 A0 IL152892 A0 IL 152892A0
Authority
IL
Israel
Prior art keywords
cannabinoid drugs
cannabinoid
drugs
tetrahydrocannabinol
mammal
Prior art date
Application number
IL15289201A
Other languages
English (en)
Inventor
Lawrence Recht
Robert B Zurier
Original Assignee
Atlantic Technology Ventures I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atlantic Technology Ventures I filed Critical Atlantic Technology Ventures I
Publication of IL152892A0 publication Critical patent/IL152892A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
IL15289201A 2000-05-17 2001-05-17 Cannabinoid drugs IL152892A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20493500P 2000-05-17 2000-05-17
PCT/US2001/016150 WO2001087297A1 (en) 2000-05-17 2001-05-17 Cannabinoid drugs

Publications (1)

Publication Number Publication Date
IL152892A0 true IL152892A0 (en) 2003-06-24

Family

ID=22760084

Family Applications (3)

Application Number Title Priority Date Filing Date
IL15289201A IL152892A0 (en) 2000-05-17 2001-05-17 Cannabinoid drugs
IL15289101A IL152891A0 (en) 2000-05-17 2001-05-17 Methods for decreasing cell proliferation based on (3r, 4r)-8-delta tetrahydrocannabinol-11-oic acids
IL152892A IL152892A (en) 2000-05-17 2002-11-17 Use of cannabinoids for the preparation of drugs for the treatment or prevention of cell culture diseases

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL15289101A IL152891A0 (en) 2000-05-17 2001-05-17 Methods for decreasing cell proliferation based on (3r, 4r)-8-delta tetrahydrocannabinol-11-oic acids
IL152892A IL152892A (en) 2000-05-17 2002-11-17 Use of cannabinoids for the preparation of drugs for the treatment or prevention of cell culture diseases

Country Status (13)

Country Link
US (2) US6448288B1 (xx)
EP (2) EP1307186A4 (xx)
JP (2) JP2003533479A (xx)
CN (2) CN1227007C (xx)
AT (1) ATE406156T1 (xx)
AU (5) AU6169501A (xx)
CA (2) CA2409005A1 (xx)
DE (1) DE60135557D1 (xx)
HU (2) HUP0700039A2 (xx)
IL (3) IL152892A0 (xx)
NZ (2) NZ523028A (xx)
RU (2) RU2272620C2 (xx)
WO (3) WO2001087296A1 (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE394124T1 (de) 2002-06-06 2008-05-15 Yissum Res Dev Co Verfahren, zusammensetzungen und herstellungsgegenstände zur modulierung des knochenwachstums
AU2003303376A1 (en) * 2002-12-19 2004-07-22 University Of Massachusetts Cannabinoid analogs as peroxisome proliferator activated nuclear receptor gamma activators
JP2007501279A (ja) * 2003-05-20 2007-01-25 ユニバーシティ・オブ・テネシー・リサーチ・ファウンデイション カンナビノイド誘導体、その製造方法、および使用
US8580842B2 (en) 2003-09-30 2013-11-12 Abbott Gmbh & Co. Kg Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
US20050070718A1 (en) 2003-09-30 2005-03-31 Abbott Gmbh & Co. Kg Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
GB2418612A (en) * 2004-10-01 2006-04-05 Gw Pharma Ltd Inhibition of tumour cell migration with cannabinoids
WO2006065792A2 (en) * 2004-12-13 2006-06-22 Indevus Pharmaceuticals, Inc. Treatment of interstitial cystitis using cannabinoid analogs
US20060128794A1 (en) * 2004-12-13 2006-06-15 Indevus Pharmaceuticals, Inc. Treatment of interstitial cystitis using (6aR,10aR)-delta8-tetrahydrocannabinol-11-OIC acids
US20070037873A1 (en) * 2005-08-08 2007-02-15 Zurier Robert B Airway remodeling treatments
US7597910B2 (en) * 2005-08-20 2009-10-06 Slgm Medical Research Institute Compositions and methods for treating prostate disorders
EP2578577A1 (en) 2005-09-29 2013-04-10 Albany Molecular Research, Inc. Sulfonyl esters of tetrahydrocannabinol and derivatives thereof
US20070093519A1 (en) * 2005-10-20 2007-04-26 Indevus Pharmaceuticals, Inc. Anti-emetic uses of cannabinoid analogs
US20070099988A1 (en) * 2005-10-31 2007-05-03 Indevus Pharmaceuticals, Inc. Anti-emetic uses of (3r, 4r)-delta8-tetrahydrocannabinol-11-oic acids
US8486979B2 (en) 2006-12-12 2013-07-16 Abbvie Inc. 1,2,4 oxadiazole compounds and methods of use thereof
US20080167286A1 (en) 2006-12-12 2008-07-10 Abbott Laboratories Pharmaceutical compositions and their methods of use
UY30846A1 (es) 2006-12-30 2008-07-31 Abbott Gmbh & Amp Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos
US7781650B2 (en) * 2007-04-30 2010-08-24 Monsanto Technology Llc Plants and seeds of corn variety CV202909
US9084771B2 (en) 2007-05-17 2015-07-21 Sutter West Bay Hospitals Methods and compositions for treating cancer
ES2455197T3 (es) 2007-12-07 2014-04-14 Abbvie Deutschland Gmbh & Co Kg Derivados de oxindol 5,6-disustituidos y el uso de los mismos para la preparación de un medicamento para el tratamiento de enfermedades dependientes de vasopresina
RU2484090C2 (ru) 2007-12-07 2013-06-10 Эбботт Гмбх Унд Ко.Кг 5-галогензамещенные производные оксиндола и их применение для лечения вазопрессинзависимых заболеваний
US8703775B2 (en) 2007-12-07 2014-04-22 AbbVie Deutschland GmbH & Co. KG Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
WO2010009775A1 (de) 2007-12-07 2010-01-28 Abbott Gmbh & Co. Kg Carbamat-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen
GB2471987B (en) 2008-06-04 2012-02-22 Gw Pharma Ltd Anti-tumoural effects of cannabinoid combinations
WO2010138600A2 (en) 2009-05-29 2010-12-02 Abbott Laboratories Pharmaceutical compositions for the treatment of pain
GB2478595B (en) 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
GB2516814B (en) 2013-06-19 2016-08-31 Otsuka Pharma Co Ltd Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
MA49773A (fr) 2017-08-04 2021-04-21 Merck Sharp & Dohme Combinaisons d'antagonistes de pd-1 et d'agonistes de sting benzo[b
MA49772A (fr) 2017-08-04 2021-04-21 Merck Sharp & Dohme Agonistes benzo[b]thiophène de sting pour le traitement du cancer
CN111233814A (zh) * 2020-03-02 2020-06-05 福建省中科生物股份有限公司 一种萜酚类化合物zkyy-057及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327028A (en) * 1978-08-17 1982-04-27 Calcol, Inc. Composition of matter
ZA885929B (en) * 1987-08-25 1989-04-26 Oxi Gene Inc Agents for use in tumor or cancer cell killing therapy
US4973603A (en) * 1988-06-16 1990-11-27 Sumner Burstein Platelet activating factor antagonist and methods of use therefor
US4880030A (en) * 1988-07-25 1989-11-14 Terry Paul E Safety flow control fluid shutoff device
US5635530A (en) * 1991-09-12 1997-06-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem (3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processors for their preparation and pharmaceutical compositions containing them
US5538993A (en) * 1991-09-12 1996-07-23 Yissum Research Development Company Certain tetrahydrocannabinol-7-oic acid derivatives
US5338753A (en) 1992-07-14 1994-08-16 Sumner H. Burstein (3R,4R)-Δ6 -tetrahydrocannabinol-7-oic acids useful as antiinflammatory agents and analgesics
US6162829A (en) * 1997-10-17 2000-12-19 Atlantic Pharmaceuticals, Inc. (3R,4R)-Δ8 -tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics
ES1045342Y (es) * 2000-02-11 2001-02-16 Alvarez Manuel Couto Expositor giratorio para postales, fotos y similares.

Also Published As

Publication number Publication date
HUP0700038A2 (en) 2007-05-02
WO2001087295A8 (en) 2003-04-10
RU2273476C2 (ru) 2006-04-10
CN1452485A (zh) 2003-10-29
AU2001263217A1 (en) 2001-11-26
CN1447685A (zh) 2003-10-08
EP1307186A4 (en) 2005-10-19
WO2001087296A1 (en) 2001-11-22
EP1307188A1 (en) 2003-05-07
DE60135557D1 (de) 2008-10-09
AU6468001A (en) 2001-11-26
CA2408961A1 (en) 2001-11-22
AU6169501A (en) 2001-11-26
EP1307188A4 (en) 2005-07-06
JP2003533478A (ja) 2003-11-11
RU2272620C2 (ru) 2006-03-27
AU2001264680B2 (en) 2006-09-14
WO2001087297A1 (en) 2001-11-22
IL152892A (en) 2010-06-30
ATE406156T1 (de) 2008-09-15
US20020022653A1 (en) 2002-02-21
US20040225011A1 (en) 2004-11-11
NZ523029A (en) 2004-11-26
WO2001087295A1 (en) 2001-11-22
US6914072B2 (en) 2005-07-05
CA2409005A1 (en) 2001-11-22
JP2003533479A (ja) 2003-11-11
NZ523028A (en) 2004-09-24
AU2001261695B2 (en) 2005-06-16
HUP0700039A2 (en) 2007-05-02
EP1307188B1 (en) 2008-08-27
US6448288B1 (en) 2002-09-10
EP1307186A1 (en) 2003-05-07
CN1227007C (zh) 2005-11-16
CN1273123C (zh) 2006-09-06
IL152891A0 (en) 2003-06-24

Similar Documents

Publication Publication Date Title
AU6468001A (en) Cannabinoid drugs
AU2002213377A1 (en) Synchronized computing
EG25614A (en) Novel pyrroles derivatives as pharmaceutical agents
LTC1284974I2 (lt) Triazoliltropano dariniai kaip CCR5 moduliatoriai
HUP0303069A3 (en) Imidazole derivatives, pharmaceutical compositions containing them and their use
AU2001282399A1 (en) Resorcinol derivatives
AU2001249502A1 (en) Organizer for computer monitor
AU2001258117A1 (en) Supports for photosensitizer formulations
SG146442A1 (en) Sulphonamide derivatives, their preparation and use as medicaments
AU2002211663A1 (en) Nf-$g(k)b inhibitors
ZA200307478B (en) Sapogenin derivatives, their synthesis and use
AU2002224038A1 (en) Benzimidazole derivatives
AU2002353128A1 (en) Bracing system for stringed instrument
GB0002336D0 (en) Medicaments
DE60045330D1 (de) Wirbelsystem für einen ionisierbares Gas verwendenden Koagulator
AUPQ836500A0 (en) Parallel execution mechanism for spreadsheets
AU2001284039A1 (en) Chromanone derivatives
EP1170006A4 (en) MEDICINES TO RELIEVE HEMICRANIA
AU2001291690A1 (en) Drugs for sex dysfunctions
AU2001288632A1 (en) N-way demultiplexer
AU2003291012A8 (en) Chroman derivatives for the reduction of inflammation symptoms
AU2001234270A1 (en) Bandage for orthopaedic use
PL359727A1 (en) Crystalline pharmaceutical
MXPA03003466A (es) Derivados de piranosido.
AU2001262932A1 (en) (bis)sulfonamide derivatives